TIAA CREF Investment Management’s Wave Life Sciences WVE Stock Holding History

TIAA CREF Investment Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.35M	Buy	34,800 +2,914	+9%	+$118K	﹤0.01%	2182
2018 Q4	$1.34M	Sell	31,886 -746	-2%	-$33.2K	﹤0.01%	2166
2018 Q3	$1.63M	Sell	32,632 -2,947	-8%	-$133K	﹤0.01%	2227
2018 Q2	$1.36M	Buy	35,579 +5,657	+19%	+$244K	﹤0.01%	2366
2018 Q1	$1.2M	Buy	29,922 +251	+0.8%	+$10.6K	﹤0.01%	2342
2017 Q4	$1.04M	Sell	29,671 -1,456	-5%	-$42.4K	﹤0.01%	2443
2017 Q3	$677K	Sell	31,127 -1,364	-4%	-$27.4K	﹤0.01%	2699
2017 Q2	$604K	Buy	32,491 +12,996	+67%	+$280K	﹤0.01%	2774
2017 Q1	$536K	Sell	19,495 -1,544	-7%	-$43.1K	﹤0.01%	2768
2016 Q4	$550K	Sell	21,039 -6,961	-25%	-$226K	﹤0.01%	2810
2016 Q3	$909	Hold	28,000	–	–	﹤0.01%	2589
2016 Q2	$579K	Buy	+28,000	New	+$436K	﹤0.01%	2800

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TIAA CREF Investment Management's WVE Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Wave Life Sciences (WVE) stake by 9.1% in Q1 2019, buying an estimated $118K and bringing the position to 34,800 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

TIAA CREF Investment Management first reported a position in WVE in Q2 2016 and has held it in 12 quarters since. The position peaked at $1.63M in Q3 2018. 110 funds tracked by Wall St. Rank hold WVE as of Q1 2019.

TIAA CREF Investment Management held 34,800 shares of Wave Life Sciences worth $1.35M as of Q1 2019.
TIAA CREF Investment Management bought 2,914 Wave Life Sciences shares in Q1 2019, an estimated $118K.
Wave Life Sciences made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2182 holding.
TIAA CREF Investment Management first reported a position in Wave Life Sciences in Q2 2016 and has held it in 12 quarters since.
TIAA CREF Investment Management's Wave Life Sciences position peaked at $1.63M in Q3 2018.
110 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.